Vaccine Prevention of Respiratory Syncytial Virus Infection in Older Adults: The Work Continues
- PMID: 29029125
- PMCID: PMC5853301
- DOI: 10.1093/infdis/jix504
Vaccine Prevention of Respiratory Syncytial Virus Infection in Older Adults: The Work Continues
Keywords: Respiratory Syncytial Virus; older adults; vaccine.
Comment on
-
An Adjuvanted, Postfusion F Protein-Based Vaccine Did Not Prevent Respiratory Syncytial Virus Illness in Older Adults.J Infect Dis. 2017 Dec 12;216(11):1362-1370. doi: 10.1093/infdis/jix503. J Infect Dis. 2017. PMID: 29029260 Free PMC article. Clinical Trial.
References
-
- Population Division, Department of Economic and Social Affairs, United Nations. World population prospects: the 2017 revision, key findings and advance tables. Working paper no. ESA/P/WP/248. New York, NY: United Nations, 2017.
-
- Falsey AR, Hennessey PA, Formica MA, Cox C, Walsh EE. Respiratory syncytial virus infection in elderly and high-risk adults. N Engl J Med 2005; 352:1749–59. - PubMed
-
- World Health Organization. WHO global RSV surveillance pilot http://www.who.int/influenza/rsv/rsv_objectives/en/. Accessed 11 September 2017.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
